fda glp-1 enforcement news october 2025 restricts non-approved compounded weight loss products GLP-1 Pipeline Update: November 2025

Enlace American Heart Association, Diet and Lifestyle Recommendations

Several studies have primarily evaluated the changes in cardiovascular risk biomarkers upon the use of GLP-1 RAs

Choose semaglutide if you want excellent results at lower cost ($199 vs $349 monthly for compounded versions), prefer potentially milder side effects, or want to start conservatively

This conversation is particularly important for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2), as these represent absolute contraindications to the use of products with the thyroid C-cell tumor boxed warning, including semaglutide, liraglutide, dulaglutide, exenatide extended-release, and tirzepatide

Poor physical performance identifies severe sarcopenia

You might shrink in size but feel softer, weaker, or less defined